Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced the composition of its board of directors and their respective roles within the company. The board consists of both executive and independent non-executive directors, with various members serving on committees such as the Audit Committee, Strategic Development and Investment Committee, Nomination and Remuneration Committee, and Budget Committee. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders and may impact the company’s strategic direction.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of medicinal products.
YTD Price Performance: -3.38%
Average Trading Volume: 1,155,070
Technical Sentiment Signal: Sell
Current Market Cap: HK$43.53B
For an in-depth examination of 0874 stock, go to TipRanks’ Overview page.